Christine J. Harrison

Author

Also Known As

C Harrison, C J Harrison, C. Harrison, C. J. HARRISON, C. J. Harrison, C.J. HARRISON, C.J. Harrison, CHRISTINE J. HARRISON, CJ Harrison, Christine Harrison

494

Publications

29.7K

Citations

H-Index

146

Concepts

All Affiliations

Newcastle University University College London University of Southampton Great Ormond Street Hospital St Anna Children's Hospital

About

Christine J. Harrison is an author at Newcastle University specializing in medicine, hematology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	74	5.7K
2	Health Sciences	21	27	1.5K
3	Engineering	6	6	446
4	Natural Sciences	5	5	180
5	Applied Physics	1	1	10

Christine J. Harrison

212

Publications

22K

Citations

H-Index

Page 1

	Year	Citations
The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 Trial David Grimwade, Helen M. Walker, Fiona Oliver, Blood	1998	2.6K
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials David Grimwade, Robert K. Hills, Anthony V. Moorman, Blood	2010	1.9K
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial Anthony V. Moorman, Christine J. Harrison, Georgina Buck, Blood	2006	728
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia Lisa J. Russell, Melania Capasso, Inga Vater, Blood	2009	492
Novel prognostic subgroups in childhood 11q23/MLL-rearranged acute myeloid leukemia: results of an international retrospective study Brian V. Balgobind, Susana C. Raimondi, Jochen Harbott, Blood	2009	444
A simple, robust, validated and highly predictive index for the determination of risk‐directed therapy in acute myeloid leukaemia derived from the MRC AML 10 trial Keith Wheatley, Alan K. Burnett, Anthony H. Goldstone, British Journal of Haematology	1999	434
Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial Anthony V. Moorman, Hannah Ensor, Sue Richards, The Lancet Oncology Hematological MalignancyLymphoid NeoplasiaPediatric HematologyMedicineHematology	2010	388
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group Libi Hertzberg, Elena Vendramini, Ithamar Ganmore, Blood	2009	344
PHF6 mutations in T-cell acute lymphoblastic leukemia Pieter Van Vlierberghe, Teresa Palomero, Hossein Khiabanian, Nature Genetics Hematological MalignancyPhf6 MutationsMixed-phenotype Acute LeukemiaHematologyAdult T-cell Leukemia-lymphoma	2010	309
Cytogenetics of Childhood Acute Myeloid Leukemia: United Kingdom Medical Research Council Treatment Trials AML 10 and 12 Christine J. Harrison, Robert K. Hills, Anthony V. Moorman, Journal of Clinical Oncology	2010	303

Page 1